Anticoagulant Citrate Dextrose A description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Anticoagulant Citrate Dextrose A

Citra Labs

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 6053, 50mL


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Description

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Citric Acid, anhydrous, USP 0.073 grams
Sodium Citrate, dihydrate, USP 0.220 grams
Dextrose, monohydrate, USP 0.245 grams
Water for Injection, USP q.s.
pH: 4.5 – 5.5

Anticoagulant Citrate Dextrose A Single patient use only, on a single occasion.

Clinical Pharmacology

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

Anticoagulant Citrate Dextrose A Indications and Usage

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Contraindications

NOT FOR DIRECT INTRAVENOUS INFUSION.

Warnings

None.

Precautions

General

Aseptic technique must be maintained at all times. ACD-A solution is a clear solution. If the product shows any cloudiness or turbidity, the product should be discarded. The ACD-A solution may exhibit a slight "yellow" color, which is acceptable and in no way impairs the safe use of the product. The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Information for Patients

None.

Laboratory Tests

There are no laboratory tests for the drug product at this time.

Drug Interactions

ACD-A is added to whole blood without any other drug products, and therefore, there are no drug interaction concerns.

Carcinogenesis, mutagenesis, impairment of fertility

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.

Pregnancy

Long-term studies in animals have not been performed to evaluate the effects of ACD-A on pregnant women.

Pediatric Use

The safety and effectiveness of ACD-A in children have not been established.

Side Effects

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Overdosage

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

Dosage and Administration

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

How Supplied

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A),

NDC REF SIZE CASE
23731-6051-5 6053 50 mL Vial 12 Vials/Case

It is recommended that the product be stored at ambient room temperature, 24°C (75°F); however, the product can be stored between 15°C (59°F) and 30°C (86°F). Protect from freezing and exposure to excessive heat should be minimized.

Rx Only

Manufactured & Distributed by:

Citra Labs™

55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411

Authorized Representative:
Biomet U.K. Ltd.
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain
United Kingdom
Phone 441.65.66.55.221

Anticoagulant Citrate Dextrose A

FL6053 08/11

PRINCIPAL DISPLAY PANEL - 50mL Bottle Label

C E 0044

ACD-A
Anticoagulant Citrate Dextrose Solution,
Solution A, U.S.P., 50mL

REF 6053

NDC 23731-6051-5

WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION.

Used as an anticoagulant in the extracorporeal blood processing with
Autologous PRP Systems in production of platelet rich plasma (PRP).
Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

Citra Labs™

55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411

EC REP
Authorized Representative:
Biomet U.K. Ltd.
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain
United Kingdom
Phone 441.65.66.55.221

Anticoagulant Citrate Dextrose A

Anticoagulant Citrate Dextrose A

ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, and TRISODIUM CITRATE DIHYDRATE SOLUTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:23731-6051
Route of Administration EXTRACORPOREAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ANHYDROUS CITRIC ACID ANHYDROUS CITRIC ACID 7.3 mg
Dextrose monohydrate ANHYDROUS DEXTROSE 24.5 mg
TRISODIUM CITRATE DIHYDRATE 22 mg

Inactive Ingredients

Ingredient Name Strength
water

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 50 in 1 BOTTLE, GLASS
2 NDC:23731-6051-5 12 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BN BN020037 2003-07-10


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.